Frontiers in Pharmacology | Neuropharmacology

Original Research

Published on 15 Nov 2023

Inhibition of rat locus coeruleus neurons by prostaglandin E2 EP3 receptors: pharmacological characterization ex vivo

in Neuropharmacology

Amaia Nazabal
Aitziber Mendiguren
Joseba Pineda

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1290605

1,646 views
1 citation

Original Research

Published on 15 Nov 2023

Antidepressant effect of bright light therapy on patients with Alzheimer’s disease and their caregivers

in Neuropharmacology

Xi Mei
Chenjun Zou
Zizhen Si
Ting Xu
Jun Hu
Xiangping Wu
Chengying Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1235406

2,383 views
1 citation

Original Research

Published on 13 Nov 2023

From the stomach to locus coeruleus: new neural substrate for ghrelin’s effects on ingestive, motivated and anxiety-like behaviors

in Neuropharmacology

Ivana Maric
Lorena López-Ferreras
Yashaswini Bhat
Mohammed Asker
Stina Börchers
Lauren Bellfy
Suyeun Byun
Janine L. Kwapis
Karolina P. Skibicka

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1286805

2,798 views
1 citation

Original Research

Published on 10 Nov 2023

Hyperconnectivity of the lateral amygdala in long-term methamphetamine abstainers negatively correlated with withdrawal duration

in Neuropharmacology

Yifan Li
Xuhao Wang
Shucai Huang
Qiuping Huang
Ru Yang
Zhenjiang Liao
Xinxin Chen
Shuhong Lin
Yongyan Shi
Chenhan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1138704

2,063 views
1 citation

Review

Published on 10 Nov 2023

Strategies targeting endoplasmic reticulum stress to improve Parkinson’s disease

in Neuropharmacology

Danni Wang
Shuhui Qu
Zaijun Zhang
Liang Tan
Xiuping Chen
Hai-Jing Zhong
Cheong-Meng Chong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1288894

4,973 views
18 citations

Original Research

Published on 09 Nov 2023

Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study

in Neuropharmacology

Xiaofang Chen
Yong Fan
Wenchao Ren
Maodi Sun
Xiaoni Guan
Meihong Xiu
Shuyun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1264591

1,544 views
1 citation

Review

Published on 09 Nov 2023

Antidepressant pharmacological mechanisms: focusing on the regulation of autophagy

in Neuropharmacology

Shimeng Lv
Guangheng Zhang
Yufei Huang
Jiamin Li
Ni Yang
Yitong Lu
Haoteng Ma
Yuexiang Ma
Jing Teng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1287234

4,797 views
4 citations

Correction

Published on 09 Nov 2023

Corrigendum: Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview

in Neuropharmacology

Canye Li
Qiming Cai
Zuanjun Su
Zhicong Chen
Jinming Cao
Feng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1318433

959 views

Original Research

Published on 07 Nov 2023

Features and mechanisms of propofol-induced protein kinase C (PKC) translocation and activation in living cells

in Neuropharmacology

Soma Noguchi
Taketoshi Kajimoto
Takuya Kumamoto
Masashi Shingai
Soshi Narasaki
Tomoaki Urabe
Serika Imamura
Kana Harada
Izumi Hide
Sigeru Tanaka

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1284586

2,148 views
3 citations

Editorial

Published on 01 Nov 2023

Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system

in Neuropharmacology

Nadezhda A. German

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1326774

1,250 views

Original Research

Published on 01 Nov 2023

Si-Ni-San alleviates early life stress-induced depression-like behaviors in adolescence via modulating Rac1 activity and associated spine plasticity in the nucleus accumbens

in Neuropharmacology

Lihong Ye
Jiayi Wu
Zuyi Liu
Di Deng
Shasha Bai
Lei Yang
Yao Xuan
Zehao Liu
Yafei Shi
Zhongqiu Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274121

2,902 views
5 citations

Original Research

Published on 01 Nov 2023

TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder

in Neuropharmacology

Dominika Dudek
Adrian Andrzej Chrobak
Anna Julia Krupa
Aleksandra Gorostowicz
Adrian Gerlich
Andrzej Juryk
Marcin Siwek

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1296639

6,266 views
7 citations

Original Research

Published on 31 Oct 2023

Ketamine promptly normalizes excess norepinephrine and enhances dopamine neuronal activity in Wistar Kyoto rats

in Neuropharmacology

Stephen Daniels
Mostafa El Mansari
Rami Hamoudeh
Pierre Blier

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1276309

3,617 views
4 citations

Original Research

Published on 26 Oct 2023

“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine

in Neuropharmacology

Mark A. Smith
Samantha L. Biancorosso
Jacob D. Camp
Salome H. Hailu
Alexandra N. Johansen
Mackenzie H. Morris
Hannah N. Carlson

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1280289

6,958 views
31 citations

Review

Published on 25 Oct 2023

Dysregulated neuromodulation in the anterior cingulate cortex in chronic pain

in Neuropharmacology

Kevin Lançon
Philippe Séguéla

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1289218

5,066 views
7 citations

Systematic Review

Published on 24 Oct 2023

A systematic review of the neuropathology and memory decline induced by monosodium glutamate in the Alzheimer’s disease-like animal model

in Neuropharmacology

Singh S. Ankul
Lakshmi Chandran
Singh Anuragh
Ilango Kaliappan
Rapuru Rushendran
Chitra Vellapandian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1283440

12,787 views
12 citations